M&T Bank Corp Sarepta Therapeutics, Inc. Transaction History

M&T Bank Corp

$29.1 Billion
Q2 2024

A detailed history of M&T Bank Corp transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, M&T Bank Corp holds 4,113 shares of SRPT stock, worth $513,713. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,113

Previous 4,260 3.45%

Holding current value

$513,713

Previous $551,000 17.79%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$113.33 - $163.85 $16,659 - $24,085	-147 Reduced 3.45%	4,113 $649,000
Q1 2024 May 07, 2024	BUY	$93.7 - $141.53 $63,997 - $96,664	683 Added 19.09%	4,260 $551,000
Q4 2023 Feb 06, 2024	SELL	$67.31 - $124.76 $336 - $623	-5 Reduced 0.14%	3,577 $344,000
Q3 2023 Nov 02, 2023	BUY	$102.5 - $123.59 $42,127 - $50,795	411 Added 12.96%	3,582 $434,000
Q2 2023 Aug 09, 2023	BUY	$106.4 - $157.19 $22,131 - $32,695	208 Added 7.02%	3,171 $363,000
Q1 2023 May 11, 2023	SELL	$117.53 - $155.99 $443,910 - $589,174	-3,777 Reduced 56.04%	2,963 $408,000
Q4 2022 Feb 13, 2023	BUY	$100.86 - $132.13 $505,106 - $661,707	5,008 Added 74.25%	11,753 $1.52 Million
Q4 2022 Feb 13, 2023	SELL	$100.86 - $132.13 $505,611 - $662,367	-5,013 Reduced 42.65%	6,740 $873,000
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $605 - $953	8 Added 0.12%	6,745 $746,000
Q2 2022 Aug 05, 2022	BUY	$62.69 - $88.44 $11,472 - $16,184	183 Added 2.79%	6,737 $505,000
Q1 2022 May 09, 2022	SELL	$63.15 - $90.42 $26,017 - $37,253	-412 Reduced 5.91%	6,554 $512,000
Q4 2021 Feb 07, 2022	BUY	$77.28 - $99.42 $10,819 - $13,918	140 Added 2.05%	6,966 $627,000
Q3 2021 Oct 28, 2021	BUY	$65.97 - $92.48 $9,631 - $13,502	146 Added 2.19%	6,826 $631,000
Q2 2021 Aug 13, 2021	BUY	$69.38 - $86.75 $42,113 - $52,657	607 Added 10.0%	6,680 $519,000
Q1 2021 May 06, 2021	SELL	$72.25 - $168.95 $23,770 - $55,584	-329 Reduced 5.14%	6,073 $453,000
Q4 2020 Feb 12, 2021	SELL	$125.56 - $178.74 $115,012 - $163,725	-916 Reduced 12.52%	6,402 $1.09 Million
Q3 2020 Nov 06, 2020	BUY	$127.12 - $172.34 $578,904 - $784,836	4,554 Added 164.76%	7,318 $1.03 Million
Q2 2020 Jul 29, 2020	SELL	$93.0 - $171.7 $9,207 - $16,998	-99 Reduced 3.46%	2,764 $443,000
Q1 2020 May 14, 2020	SELL	$82.38 - $131.64 $4,778 - $7,635	-58 Reduced 1.99%	2,863 $279,000
Q4 2019 Feb 07, 2020	BUY	$76.53 - $135.58 $6,734 - $11,931	88 Added 3.11%	2,921 $377,000
Q3 2019 Nov 12, 2019	BUY	$72.81 - $156.91 $52,204 - $112,504	717 Added 33.88%	2,833 $213,000
Q2 2019 Aug 12, 2019	SELL	$112.21 - $151.95 $217,687 - $294,783	-1,940 Reduced 47.83%	2,116 $321,000
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $114,883 - $163,359	1,077 Added 36.15%	4,056 $484,000
Q4 2018 Feb 01, 2019	BUY	$97.32 - $148.76 $11,094 - $16,958	114 Added 3.98%	2,979 $325,000
Q3 2018 Nov 09, 2018	BUY	$115.31 - $161.51 $330,363 - $462,726	2,865 New	2,865 $464,000

Others Institutions Holding SRPT

# of Institutions

561

Shares Held

85.5M

Call Options Held

3.67M

Put Options Held

1.75M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account